BCRX FY 2014 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M-21.5% YoY

Gross Profit

$13M99.1% margin

Operating Income

-$46M-336.4% margin

Net Income

-$45M-332.1% margin

EPS (Diluted)

$-0.68

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$39M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$137M

Total Liabilities

$61M

Stockholders' Equity

-$468M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$17M	-21.5%
Gross Profit	$13M	$17M	-21.7%
Operating Income	-$46M	-$31M	-49.0%
Net Income	-$45M	-$30M	-50.1%